Optimizing FLT3 Inhibitor Use in Adult Acute Myeloid Leukemia with FLT3 Mutations Using Proteomics

被引：0
|
作者：
Magalhaes, Eduardo Sabino [1 ]
Hubner, Stefan [2 ]
Brown, Brandon D. [3 ]
Qiu, Yihua [4 ]
Kornblau, Steven M. [4 ]
机构：
[1] Univ Med Ctr Groningen, Dept Ageing Biol, ERIBA, Groningen, Netherlands
[2] Univ Texas Med Branch UTMB, John Sealy Sch Med, Galveston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Pediat, Houston, TX USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-186508
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] FLT3 MUTATIONS IN ACUTE MYELOID LEUKEMIA IN CHILDHOOD
    Alonso, Cristina
    Rubio, Patricia
    Gallego, Marta
    Medina, Adriana
    Rossi, Jorge
    Felice, Maria
    PEDIATRIC BLOOD & CANCER, 2011, 57 (05) : 767 - 767
  • [2] Targeting FLT3 Mutations in Acute Myeloid Leukemia
    El Fakih, Riad
    Rasheed, Walid
    Hawsawi, Yousef
    Alsermani, Maamoun
    Hassanein, Mona
    CELLS, 2018, 7 (01)
  • [3] Implications of FLT3 Mutations in the Therapy of Acute Myeloid Leukemia
    Mattison, Ryan J.
    Ostler, Kelly R.
    Locke, Frederick L.
    Godley, Lucy A.
    REVIEWS ON RECENT CLINICAL TRIALS, 2007, 2 (02) : 135 - 141
  • [4] FLT3 mutations in acute myeloid leukemia cell lines
    Quentmeier, H
    Reinhardt, J
    Zaborski, M
    Drexler, HG
    LEUKEMIA, 2003, 17 (01) : 120 - 124
  • [5] Discovery of SILA-123 as a Highly Potent FLT3 Inhibitor for the Treatment of Acute Myeloid Leukemia with Various FLT3 Mutations
    Wei, Tian-Hua
    Wang, Zi-Xuan
    Lu, Meng-Yi
    Xu, Yu-Jing
    Yang, Jin
    Ni, Xing-Feng
    Cheng, Yang
    Zhang, Meng-Yuan
    Liu, Jia-Chuan
    Li, Qing-Qing
    Cai, Jiao
    Chen, Zi-Jun
    Kang, Ji-Bo
    Li, Nan
    Dai, Wei-Chen
    Ding, Ning
    Yu, Yan-Cheng
    Leng, Xue-Jiao
    Xue, Xin
    Wang, Xiao-Long
    Sun, Shan-Liang
    Yang, Ye
    Li, Nian-Guang
    Shi, Zhi-Hao
    JOURNAL OF MEDICINAL CHEMISTRY, 2024,
  • [6] Midostaurin for Patients With Acute Myeloid Leukemia and FLT3 Mutations
    Levis, Mark James
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (06) : 323 - 325
  • [7] FLT3 mutations in acute myeloid leukemia cell lines
    H Quentmeier
    J Reinhardt
    M Zaborski
    H G Drexler
    Leukemia, 2003, 17 : 120 - 124
  • [8] The MERTK/FLT3 inhibitor MRX-2843 overcomes resistance-conferring FLT3 mutations in acute myeloid leukemia
    Minson, Katherine A.
    Smith, Catherine C.
    DeRyckere, Deborah
    Libbrecht, Clara
    Lee-Sherick, Alisa B.
    Huey, Madeline G.
    Lasater, Elisabeth A.
    Kirkpatrick, Gregory D.
    Stashko, Michael A.
    Zhang, Weihe
    Jordan, Craig T.
    Kireev, Dmitri
    Wang, Xiaodong
    Frye, Stephen V.
    Earp, H. Shelton
    Shah, Neil P.
    Graham, Douglas K.
    JCI INSIGHT, 2016, 1 (03)
  • [9] FLT3 Inhibition in Acute Myeloid Leukemia
    Smith, Catherine C.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S5 - S6
  • [10] FLT3 inhibitors in acute myeloid leukemia
    Wu, Mei
    Li, Chuntuan
    Zhu, Xiongpeng
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
12345